Vistagen Therapeutics, Inc. - Common Stock (VTGN)
0.7778
+0.0378 (5.11%)
NASDAQ · Last Trade: Dec 19th, 4:18 PM EST
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill · December 19, 2025
Let's have a look at the stocks with an unusual volume in today's session.
Via Chartmill · December 18, 2025
Why Did Vistagen Stock Tank 82% Today?stocktwits.com
Via Stocktwits · December 17, 2025
Via Benzinga · November 17, 2025
Vistagen (VTGN) Q2 2026 Earnings Call Transcript
Via The Motley Fool · November 14, 2025
Via Benzinga · November 12, 2025
Via Benzinga · August 6, 2025

VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.
Via InvestorPlace · August 13, 2024

Investors looking for millionaire status in the coming years should consider three stocks under $15 that could be worth buying.
Via InvestorPlace · July 26, 2024

VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024.
Via InvestorPlace · June 12, 2024

Though volatility remains high, these penny stocks promise significant returns, especially in this high-interest rate economic climate.
Via InvestorPlace · May 14, 2024

The internet and forums such as Reddit, are rife with misinformation about stock prospects. However, these three might have potential.
Via InvestorPlace · May 13, 2024

Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy.
Via InvestorPlace · April 19, 2024

Explore three stocks under $10 in electronic equipment and instruments, technology hardware, storage and peripherals, and biotechnology.
Via InvestorPlace · April 9, 2024

Learn the potency of lesser-known stocks and explore their fundamental edge in technology distribution, food retail, and biotechnology.
Via InvestorPlace · March 31, 2024

Via Benzinga · February 19, 2024

Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities.
Via InvestorPlace · February 19, 2024

Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation.
Via InvestorPlace · February 14, 2024

